Tag : genomics

Tempus, a leader in artificial intelligence and precision medicine, today announced a multi-year agreement with the United States Department of Veterans Affairs (VA) National Precision...

Clue Genetics Inc. (Clue) has announced its acquisition of certain R&D assets of Mycosynthetix, Inc. (MSX), including its proprietary collection of approximately 50,000 diverse strains...

CLS’ Corigen® Medication Safety Program is recognized as the most comprehensive solution on the market As Coriell Life Sciences (CLS) leads the way in unlocking the power of pharmacogenomics...

Mind Genomics, founded by Dr. Howard Moskowitz, a Pioneer of Segmentation Strategies with a Ph.D. in Experimental Psychology from Harvard University has been doing that for years. Howard...

Avance Biosciences, a leading CRO providing GLP/GMP-compliant assay development, assay validation, and sample testing services supporting biological drug development and manufacturing, announced today completion of...

First-of-its-kind partnership will identify drug targets and accelerate novel therapy development using genomics and artificial intelligence Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing...

Technology tackles complexity of human manipulation, enabling robotic dexterity Australia-based company Contactile has closed US$2.5 million in seed funding to develop and pilot tactile sensors that give...

The Genomic Sequencing Advocates Network (GSAN) recently issued an open letter to the Intergovernmental Negotiating Body (INB) of the World Health Assembly, in which they...

Q1 2022 revenue growth of 8% over prior year 10x Genomics, Inc. (Nasdaq: TXG) today reported financial results for the first quarter ended March 31, 2022. Recent...

Discovering new ways to treat heart and lung diseases by tapping into the natural disease resistance of hibernating animals is the focus of a new...